BioCryst Pharmaceuticals
BCRX
#4706
Rank
HK$12.52 B
Marketcap
HK$60.49
Share price
1.43%
Change (1 day)
54.61%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): -HK$9.79

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$9.72. In 2022 the company made an earnings per share (EPS) of -HK$10.34 a decrease over its 2021 EPS that were of -HK$8.01.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$9.79-5.32%
2022-HK$10.3429.13%
2021-HK$8.01-4.63%
2020-HK$8.4010.2%
2019-HK$7.620%
2018-HK$7.6225.64%
2017-HK$6.064%
2016-HK$5.8327.12%
2015-HK$4.59-13.24%
2014-HK$5.2923.64%
2013-HK$4.28-30.38%
2012-HK$6.14-37.3%
2011-HK$9.8065.79%
2010-HK$5.91117.14%
2009-HK$2.72-46.15%
2008-HK$5.05-26.97%
2007-HK$6.92-40.67%
2006-HK$11.6648.51%
2005-HK$7.851%
2004-HK$7.7738.89%
2003-HK$5.60-25%
2002-HK$7.46231.03%
2001-HK$2.25-56.72%
2000-HK$5.2191.43%
1999-HK$2.722.94%
1998-HK$2.64-55.84%
1997-HK$5.9911.59%
1996-HK$5.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$16.25-267.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$60.87 526.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$4.59-52.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$55.90 475.20%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$34.13-451.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$18.66 92.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.22-380.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$93.92 866.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$5.99-38.40%๐Ÿ‡บ๐Ÿ‡ธ USA